Breakdown | ||||
Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
1.23B | 1.34B | 932.64M | 534.82M | 499.63M | Gross Profit |
756.21M | 112.62M | 588.60M | 322.54M | 303.12M | EBIT |
673.09M | 54.22M | 77.84M | 84.88M | 79.37M | EBITDA |
295.55M | 780.51M | 555.62M | 287.60M | 274.18M | Net Income Common Stockholders |
-654.49M | -278.26M | -106.00M | 14.32M | 19.19M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
68.92M | 25.70M | 60.96M | 13.18M | 15.30M | Total Assets |
10.65B | 12.64B | 13.85B | 4.26B | 3.81B | Total Debt |
296.85M | 5.30B | 5.70B | 1.92B | 1.71B | Net Debt |
227.93M | 5.27B | 5.64B | 1.91B | 1.70B | Total Liabilities |
5.35B | 5.71B | 6.17B | 2.07B | 1.86B | Stockholders Equity |
5.23B | 6.82B | 7.57B | 2.19B | 1.95B |
Cash Flow | Free Cash Flow | |||
501.62M | 268.79M | 109.20M | 131.94M | 376.13M | Operating Cash Flow |
501.62M | 499.82M | 272.75M | 232.63M | 470.09M | Investing Cash Flow |
900.92M | 349.14M | 1.63B | -562.47M | -555.17M | Financing Cash Flow |
-1.36B | -884.22M | -1.86B | 327.72M | 99.72M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
78 Outperform | $98.70B | 186.70 | 1.65% | 1.67% | 20.40% | 57.80% | |
73 Outperform | $14.60B | 57.09 | 2.89% | 5.91% | 23.82% | -37.59% | |
72 Outperform | $1.59B | 17.08 | 9.48% | 6.37% | 6.54% | -4.13% | |
65 Neutral | $6.01B | ― | -12.50% | 7.24% | -5.62% | -140.10% | |
63 Neutral | $31.32B | 358.18 | 0.75% | 2.56% | 9.48% | ― | |
61 Neutral | $4.91B | 18.99 | -3.12% | 7.77% | 6.71% | -19.69% | |
56 Neutral | $3.39B | ― | -47.99% | 7.96% | 14.19% | -331.18% |
On February 28, 2025, Healthcare Realty Trust announced its participation in Citi’s 2025 Global Property CEO Conference scheduled for March 3-4, 2025, and released an updated investor presentation. Additionally, the company reported partial rent collection from Prospect Medical, which filed for Chapter 11 bankruptcy in January 2025. Healthcare Realty collected $0.4 million in rent for January and February 2025, but there is uncertainty regarding the recovery of additional unpaid rent or the ability to relet the space.
Healthcare Realty Trust reported a net loss of $106.8 million for the fourth quarter ending December 31, 2024, and declared a quarterly dividend of $0.31 per share. Despite the loss, the company achieved a normalized FFO per share of $0.40, at the high end of its guidance range, and experienced growth in leasing activities with a record 686,000 square feet of new leases. Furthermore, the company undertook significant capital allocation efforts, closing $522 million in joint ventures and asset sales, and reducing its leverage by repaying a $350 million term loan. Leadership changes were also announced, with Connie Moore appointed as Interim President & CEO, and a search is underway for a permanent leader.
Healthcare Realty Trust has announced key leadership changes with Austen Helfrich appointed as the permanent Executive Vice President and Chief Financial Officer, bringing significant financial expertise from his previous roles. Andrew Loope is set to become the Executive Vice President, General Counsel, and Secretary, taking over from John Bryant who will stay as Senior Vice President, Legal Affairs. These strategic appointments aim to drive long-term shareholder value and continue the company’s growth in the medical real estate sector.
Healthcare Realty Trust has revamped its Board of Directors by electing Tom Bohjalian as the Independent Chair and appointing three seasoned industry veterans, David Henry, Glenn Rufrano, and Don Wood, as new independent directors. This strategic move aligns with a cooperation agreement with Starboard Value, aimed at enhancing shareholder value and driving sustainable growth. The changes follow the retirement of several board members, positioning the company for improved execution of its financial and operational objectives.